ARCHIVE

• Ranbaxy Acquires GSK's Generic Drug Business in Spain
  July 31, 2006

• Wholesalers Have Not Yet Even Offered New Prices: NPhA
  July 31, 2006

• Japanese Version of Critical Path Opportunity Report Published by JPMA
  July 31, 2006

• Asahi Kasei Sees Healthcare as Core "High Growth Business"
  July 31, 2006

• R&D NEWS IN BRIEF
  July 31, 2006

• Original Clarithromycin Tastes Better than Generics: Taisho Toyama
  July 31, 2006

• Drug Development Beyond Borders　-Today's Global Cooperative Clinical Trials-　Part III: Pfizer's Views
  July 31, 2006

• Acquisition of Schering AG Should Boost Profitability: Bayer Yakuhin
  July 31, 2006

• BUSINESS NEWS IN BRIEF
  July 24, 2006

• REGULATORY NEWS IN BRIEF
  July 24, 2006

• Ryukaikon Should Settle Old Problems before Tackling New Ones: JPMA
  July 24, 2006

• InCROM Increases Number of Beds for Clinical Trials
  July 24, 2006

• Bushu Aims to Become No. 1 Contract Drug Maker in Japan
  July 24, 2006

• Astellas to Promote Vesicare as 1st Choice OAB Treatment
  July 24, 2006

• SUEVEY
  July 24, 2006

• Teijin Pharma to Focus on New Drug Development in the US, Europe
  July 24, 2006

• PII Study on Implanted Cardiac Assist Device Initiated
  July 24, 2006

• Torrent Seeks Alliances with Japanese Companies
  July 24, 2006

• Annual NHI Price Revision Would Cause Confusion: Mr Henmi of Nichibyokyo
  July 24, 2006

• Sysmex America Receives Premier Pinnacle Award
  July 24, 2006

ページ

• « 先頭
• ‹ Prev
• …
• 391
• 392
• 393
• 394
• 395
• 396
• 397
• 398
• 399
• …
• Next ›
• 最終 »